Inhibitors of SARS-CoV-2 Assembly

Dr. Dirk Jochmans holds the position of research manager at the Rega Institute, University of Leuven, Belgium. He obtained a PhD in the field of antiviral immunology in 1999 after which he started his professional career at the antiviral company Tibotec, later acquired by J&J. Since 2010 he joined the Rega Institute. He has extensive experience in studying antiviral strategies for HIV, Coronavirus, Paramyxovirus, RSV and Rabies. In his work he pays special attention to the use of organoid systems (lung, brain, muscle), and the study of antiviral drug resistance.